0.5ml Prevenar Pneumococcal Polysaccharide Conjugate Vaccine

Send Inquiry

Request To Call Back

0.5ml Prevenar Pneumococcal Polysaccharide Conjugate Vaccine

Name: 0.5ml Prevenar Pneumococcal Polysaccharide Conjugate Vaccine
Brand: New Delhi Speciality Pharma
Price: 3200 INR
Availability: InStock

Price 3200 INR/ Piece

Get a Price/Quote

MOQ : 1 Piece

0.5ml Prevenar Pneumococcal Polysaccharide Conjugate Vaccine Specification

Pacakaging (Quantity Per Box)
1 pre-filled syringe

Life Span
36 months

Dosage Form
Injection

Origin of Medicine
Imported

Indication
Pneumonia and invasive pneumococcal disease

Brand Name
Prevenar 13

Packaging Type
Pre-filled syringe

Salt Composition
Pneumococcal polysaccharide conjugate

Drug Type
Vaccine

Ingredients
Pneumococcal polysaccharide conjugate (13-valent), with CRM197 protein

Physical Form
Liquid

Function
Immunization against pneumococcal disease

Recommended For
Children aged 6 weeks to 17 years

Dosage
0.5 ml per injection

Dosage Guidelines
As directed by physician

Suitable For
Pediatric

Quantity
0.5 ml

Storage Instructions
Store at 2-8C, do not freeze

Needle
Included

Sterility
Sterile

Color
Clear, colorless

Child Age Range
6 weeks-17 years

Vaccine Type
Conjugate (PCV13)

Box Contains
1 dose

Application Area
Intramuscular use

Single Dose
Yes

Presentation
Ready-to-use PFS

Prescription Status
Prescription only

0.5ml Prevenar Pneumococcal Polysaccharide Conjugate Vaccine Trade Information

Minimum Order Quantity
1 Piece

Payment Terms
Cash in Advance (CID)

Supply Ability
10 Pieces Per Month

Delivery Time
5-7 Days

Main Domestic Market
All India

About 0.5ml Prevenar Pneumococcal Polysaccharide Conjugate Vaccine

Presenting Prevenar 13, the dominant and exceptional choice in pediatric protection against pneumococcal disease. This fresh 0.5ml pre-filled syringe offers incomparable effectiveness, rapidly gaining favorable reviews from healthcare professionals worldwide. Designed as a sterile, single-dose, ready-to-use conjugate vaccine (PCV13), Prevenar 13 is intended for intramuscular application in children aged 6 weeks to 17 years. The colorless, clear solution contains pneumococcal polysaccharide conjugate with CRM197 protein and comes in a secure, easy-to-use package. Ideal for immunization programs, this imported, prescription-only vaccine ensures safe and reliable prevention of pneumonia and invasive pneumococcal conditions.

Commercial Benefits & Applications of Prevenar 13 Vaccine

The 0.5ml Prevenar Pneumococcal Polysaccharide Conjugate Vaccine is highly sought for commercial use by hospitals, clinics, and vaccination centers. Used for immunization against pneumonia and invasive pneumococcal diseases, it is a critical choice for pediatric protection. Applications include routine vaccination schedules and government immunization programs, offering reliability and efficacy in protecting children. Its ready-to-use presentation ensures smooth workflow for medical professionals and maximizes immunization coverage across a wide pediatric age range.

Domestic Market Reach & Packaging Options for Prevenar 13

Prevenar 13 is widely distributed in India's main domestic markets with a focus on quick dispatch and reliable delivery. Each proposal for supply meets stringent standards, and packaging details include a secure 0.5ml pre-filled syringe in every box. With responsive processing and prompt shipment, our logistical team ensures that healthcare providers receive their orders swiftly and in optimal condition, making us a trusted exporter, supplier, and trader in the region.

FAQ's of 0.5ml Prevenar Pneumococcal Polysaccharide Conjugate Vaccine:

Q: How should the Prevenar 13 vaccine be administered?

A: Prevenar 13 is administered as a 0.5ml intramuscular injection, typically in the thigh or upper arm of children, following the dosage guidelines prescribed by a physician.

Q: What is the main benefit of using the Prevenar 13 vaccine for children?

A: The main benefit is the prevention of pneumonia and invasive pneumococcal diseases in children aged 6 weeks to 17 years, offering broad protection against 13 types of pneumococcal bacteria.

Q: When is the recommended age range for receiving the Prevenar 13 vaccine?

A: Prevenar 13 is recommended for children from 6 weeks old up to 17 years, as per prescribed immunization schedules.

Q: Where should the Prevenar 13 vaccine be stored before administration?

A: The vaccine should be stored in a refrigerator at 2-8C and must not be frozen to maintain its sterility and effectiveness.

Q: What is the process for ordering Prevenar 13 in India?

A: Orders can be placed through registered exporters, suppliers, or traders, with quick dispatch and secure packaging for delivery across India's domestic markets.

Q: Can Prevenar 13 be used for adults or only for pediatric use?

A: This vaccine is specifically formulated and recommended for pediatric use in children aged 6 weeks to 17 years, and should be used as directed by a healthcare provider.

Tell us about your requirement